You are not logged in.

Request for Proposals - Supply of Metoprolol Succinate to DHB Hospitals and/or Community Pharmacies

Details

Tender Closed
RFx ID : 18243995
Tender Name : Request for Proposals - Supply of Metoprolol Succinate to DHB Hospitals and/or Community Pharmacies
Reference # : A984067
Open Date : Friday, 16 December 2016 9:00 AM (Pacific/Auckland UTC+13:00)
Close Date  : Friday, 27 January 2017 4:00 PM (Pacific/Auckland UTC+13:00)
Tender Type : Request for Proposals (RFP)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Matthew Wolfenden
procurement@pharmac.govt.nz
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :
Overview

REQUEST FOR PROPOSALS - SUPPLY OF METOPROLOL SUCCINATE TO DHB HOSPITALS AND/OR TO COMMUNITY PHARMACIES

PHARMAC invites proposals for the supply of metoprolol succinate controlled-release tablets (metoprolol) in New Zealand.

This request for proposals (RFP) letter incorporates the following schedules:

Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
Schedule 4 contains the RFP form in which you are to provide details of your proposal.

If you wish to submit a proposal in relation to community supply and/or hospital supply, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4 pm (New Zealand time) on Friday 27 January 2017.

If you have any inquiries about this RFP you should submit them via GETS or alternatively contact Matthew Wolfenden, Procurement Manager, by email procurement@pharmac.govt.nz.

We look forward to receiving your proposal.

RFx Outcome

This tender has been awarded to:

  • AstraZeneca

Further Award Information:
PHARMAC is pleased to announce the approval of an agreement with AstraZeneca Pty Limited for the supply of metoprolol succinate long-acting tablets.

This was the subject of a consultation letter dated 29 March 2017.

For more details please visit our website:
www.pharmac.govt.nz/news/notification-2017-06-02-metoprolol-succinate/

Award Date: Thursday, 8 June 2017 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Friday, 27 January 2017 4:02 PM (Pacific/Auckland UTC+13:00)